What does the FDA's decision mean for them and the people whose treatment is at risk of being disrupted, or at least made more expensive
Units are volumetric and depend on the solutions mg/mL
You should be especially cautious and speak with a provider if you have persistent nausea or vomiting, severe reflux, abdominal pain, a history of pancreatitis, gallbladder disease, liver disease, diabetes, low blood sugar episodes, frequent dehydration, a history of alcohol use disorder, alcohol withdrawal symptoms, or medications that should not be mixed with alcohol
Drug choice, dose, and penetration : Differences among GLP-1 RAs in ability to affect the brain (bloodbrain barrier penetration, receptor binding, half-life, dosing) may influence outcomes
Further randomized controlled trials are needed to confirm these results